Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114295712 | 11429571 | 2 | F | 20160203 | 20150828 | 20160816 | PER | US-ROCHE-1217824 | ROCHE | 0.00 | A | F | Y | 0.00000 | 20160816 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114295712 | 11429571 | 1 | PS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Unknown | U | 103964 | 180 | UG | ||||||||
| 114295712 | 11429571 | 2 | SS | COPEGUS | RIBAVIRIN | 1 | Unknown | Y | 21511 | 1200 | MG | ||||||||
| 114295712 | 11429571 | 3 | SS | COPEGUS | RIBAVIRIN | 1 | Unknown | DOSE REDUCED | Y | 21511 | 600 | MG | |||||||
| 114295712 | 11429571 | 4 | SS | INCIVEK | TELAPREVIR | 1 | Unknown | U | 0 | 750 | MG | Q8H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114295712 | 11429571 | 1 | Hepatitis C |
| 114295712 | 11429571 | 2 | Hepatitis C |
| 114295712 | 11429571 | 4 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114295712 | 11429571 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114295712 | 11429571 | Anaemia | |
| 114295712 | 11429571 | Drug reaction with eosinophilia and systemic symptoms | |
| 114295712 | 11429571 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |